A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation

Translational read-through-inducing drugs (TRIDs) promote read-through of nonsense mutations, placing them in the spotlight of current gene-based therapeutic research. Here, we compare for the first time the relative efficacies of new-generation aminoglycosides NB30, NB54 and the chemical compound P...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldmann, Tobias, Overlack, Nora, Möller, Fabian, Belakhov, Valery, van Wyk, Michiel, Baasov, Timor, Wolfrum, Uwe, Nagel-Wolfrum, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2012
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494875/
https://www.ncbi.nlm.nih.gov/pubmed/23027640
http://dx.doi.org/10.1002/emmm.201201438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494875/
https://www.ncbi.nlm.nih.gov/pubmed/23027640
http://dx.doi.org/10.1002/emmm.201201438

Ejemplares similares